ArticleAnnals of medicine2025

Serum free light chain level-based and non-fixed cycle daratumumab treatment strategy for patients with light chain amyloidosis.

Zhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.